Filing Details
- Accession Number:
- 0001835830-24-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-04 18:13:53
- Reporting Period:
- 2024-02-29
- Accepted Time:
- 2024-03-04 18:13:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1835830 | Klaviyo Inc. | KVYO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1716921 | Tony Weisman | C/O Klaviyo, Inc. 125 Summer Street, 6Th Floor Boston MA 02110 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Series A Common Stock | Acquisiton | 2024-02-29 | 33,333 | $0.00 | 33,333 | No | 4 | C | Direct | |
Series A Common Stock | Disposition | 2024-02-29 | 33,333 | $25.97 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Series A Common Stock | Series B Common Stock | Disposition | 2024-02-29 | 33,333 | $0.00 | 33,333 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,000 | No | 4 | C | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Series A Common Stock | Series B Common Stock | $0.00 | 20,833 | 20,833 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
20,833 | 20,833 | Indirect |
Footnotes
- Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.91 to $26.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Consists of (a) 66,667 shares of Series B Common Stock and (b) 8,333 unvested restricted stock units. On March 1, 2024, the remaining 8,333 RSUs vested and settled as 8,333 shares of Series B Common Stock according to the previously reported vesting schedule applicable to such grant.
- Shares held by Tony G. Weisman TTEE Tony G. Weisman Declaration of Trust Dated 06-27-2000, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.